mRNA-4157, BCG VACCINE
V940-011
Phase 2 small_molecule active
Quick answer
mRNA-4157, BCG VACCINE for Bladder cancer is a Phase 2 program (small_molecule) at Merck Sharp and Dohme with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Merck Sharp and Dohme
- Indication
- Bladder cancer
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active